Blood proteins may flag ALS before symptoms appear

A Nature Medicine study reports plasma proteomics can predict the shift to clinically evident ALS, hinting at earlier intervention.

A study in Nature Medicine reports that longitudinal plasma proteomics — tracking proteins in blood over time — can predict the conversion to clinically manifest ALS. In principle, spotting the disease before symptoms become obvious opens a window to intervene earlier, when treatment might do more good.

That matters for health because ALS is typically diagnosed only after symptoms emerge, by which point damage is advanced. A reliable blood-based predictive marker could reshape how the disease is caught and studied. We could not reach the source, so we cannot report the study's sample size, how far ahead predictions were made, or how accurate they were. Those details rest with the original paper.

Source: Nature Medicine